Piper Sandler cuts ServiceNow stock price target on deal delays By Investing.com

Piper Sandler cut ServiceNow’s price target to $140 from $200 while keeping an Overweight rating, citing on-premise deal pushouts, slipped deals, and a flat organic guide after first-quarter results. The company reported Q1 fiscal 2026 EPS of $0.97 in line with consensus and revenue of $3.770 billion versus $3.746 billion expected, but management also faced margin and guidance concerns from multiple analysts. Offset to the caution, ServiceNow raised its Now Assist ACV target to $1.5 billion, reinforcing AI momentum across the platform.

Analysis

The market is reacting less to a bad quarter than to a credibility reset: the issue is not demand vanishing, but deal timing becoming less reliable while the company is asking investors to underwrite a more ambitious AI monetization path. That combination usually compresses the multiple twice — first on near-term revenue visibility, then again if management has to spend to re-accelerate bookings. In software, that’s the classic setup where fundamentals look “fine” on a GAAP basis but the stock rerates lower because the path to the next leg of growth gets pushed out 2-4 quarters.

The second-order implication is that AI enthusiasm is now doing more work than it should in the valuation debate. Raising the AI ACV ambition helps sentiment, but it can also mask weakness in the legacy workflow engine if investors start treating AI attach as a substitute for core pipeline health. If execution remains uneven, competitors with simpler sales motions and faster implementation cycles can win incremental deals in the next two quarters, especially where procurement is already cautious and large on-premise transitions are being deferred.

The setup looks oversold tactically, but not yet structurally cheap enough to chase aggressively until the market sees evidence that the pushouts are timing noise rather than a budget reallocation trend. The key reversal catalyst is not another AI headline; it is a clean sequential acceleration in cRPO/bookings and a narrower variance between guidance and actual billings over the next 1-2 quarters. If that does not happen, the stock can stay range-bound to lower even if revenue growth remains respectable, because the market will keep discounting durability risk more than headline growth.

Key Decisions for Investors

• Short-term: trade a tactical long in NOW only on confirmation of stabilization in the next update; prefer selling put spreads over outright stock to define risk. Example: 30-60 DTE put spread targeting a 10-15% rebound if management proves bookings have normalized.
• Medium-term: avoid buying the dip aggressively until booking metrics re-accelerate; use a wait-and-see posture for 1-2 quarters. Risk/reward is poor if the organic guide remains flat while the market continues to de-rate the multiple.
• Pair trade: long higher-quality enterprise software with cleaner execution and shorter sales cycles versus short NOW. The relative-value edge is that capital is likely to migrate toward names with less implementation friction if macro caution persists.
• For existing longs, hedge with collars or calls against a recovery only after the stock confirms a higher low; if it loses the recent trough decisively, downside can extend another 10-15% as valuation support shifts lower.